The current financial score of Prothena Corporation PLC is 7.84. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 1.01M, representing a year-over-year decrease of 77.15%, while its net profit experienced a year-over-year decrease of 85.22%.
The current valuation score of Prothena Corporation PLC is 7.66. Its current P/E ratio is -2.96, which is -63.62% below the recent high of -1.08 and -1221.90% above the recent low of -39.18.
The current earnings forecast score of Prothena Corporation PLC is 6.67. The average price target is 21.40, with a high of 36.00 and a low of 8.00.
The current price momentum score of Prothena Corporation PLC is 3.73. Currently, the stock price is trading between the resistance level at 9.39 and the support level at 7.72, making it suitable for range-bound swing trading.
The current institutional shareholding score of Prothena Corporation PLC is 10.00. The latest institutional shareholding proportion is 96.24%, representing a quarter-over-quarter increase of 19.52%. The largest institutional shareholder is James Simons, holding a total of 697.62K shares, representing 0.01% of shares outstanding, with 109.33% increase in holdings.
The current risk assessment score of Prothena Corporation PLC is 6.50. The company's beta value is -0.25. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.